340B compliance depends heavily on accurate information. Covered entities have to manage data about patients, outpatient sites, pharmacies, Medicaid billing, drug purchases, and other program activities. Even a small data error can create a compliance problem if it affects how 340B drugs are purchased, dispensed, or reported.

340B data validation helps covered entities find these problems before they turn into larger compliance issues. By regularly checking data against reliable records and program requirements, organizations can improve their controls and be better prepared for audits.

What Is 340B Data Validation?

340B data validation is the process of checking 340B-related data for accuracy, completeness, and consistency.

The process can include reviewing information from pharmacy systems, EHRs, claims, purchasing records, Medicaid data, contract pharmacy records, and the HRSA 340B Office of Pharmacy Affairs Information System (OPAIS).

The goal is simple. The information used to manage the 340B program should match the organization’s actual operations.

This matters because HRSA requires covered entities to maintain accurate records and prepare for audits. Its audit process can review eligibility, internal controls, diversion, duplicate discounts, OPAIS information, and other 340B requirements.

Why Does Data Accuracy Matter for 340B Compliance?

Data is at the center of many 340B processes.

For example, a covered entity may use data to determine whether a prescription is connected to an eligible patient, whether an outpatient location is properly registered, or whether a Medicaid claim should be included in a particular billing arrangement.

If the source data is wrong, the decision based on that data may also be wrong.

Common problems can include:

• Incorrect or outdated OPAIS information
• Incomplete Medicaid Exclusion File information
• Incorrect outpatient site data
• Inconsistent patient records
• Contract pharmacy data errors
• Mismatched purchasing and dispensing records
• Incorrect billing information

HRSA’s recent audit results show why these issues deserve attention. Finalized audit findings have included incorrect OPAIS records and inaccurate or incomplete Medicaid Exclusion File information. Some findings have also involved diversion and duplicate discounts.

How Can Data Validation Reduce 340B Compliance Risk?

Data validation can reduce risk by finding inconsistencies before they become audit findings or require corrective action.

1. It Helps Identify Incorrect Registration Data

Covered entities need to keep their OPAIS information accurate and up to date. This includes information about eligible sites and contract pharmacies.

A regular data review can compare the information in OPAIS with the organization’s current records.

For example, a covered entity may discover that a location has changed, a contract pharmacy is no longer active, or another registration detail needs to be updated.

Finding these issues early gives the organization an opportunity to correct them before they create a larger problem.

2. It Supports Patient Eligibility Controls

Patient eligibility is an important part of preventing diversion.

Data validation can help organizations compare information across relevant systems and identify transactions that may need further review.

This does not mean that software should make every compliance decision automatically. Instead, validation can flag unusual or inconsistent records so the appropriate compliance or pharmacy team can investigate them.

3. It Helps Prevent Duplicate Discounts

Federal law prohibits manufacturers from providing both a 340B discount and a Medicaid drug rebate for the same drug. Covered entities must have mechanisms in place to prevent duplicate discounts.

This makes Medicaid-related data particularly important.

Validation can help identify differences between billing information and the organization’s Medicaid Exclusion File status. It can also help teams check whether internal billing practices match their documented 340B processes.

A data issue does not automatically mean a duplicate discount occurred. It does mean the record deserves attention.

4. It Makes Audit Preparation Easier

An audit can require organizations to provide records and demonstrate how their internal controls work.

HRSA states that auditors review selected 340B data and internal controls during covered entity audits. They may also review policies, eligibility information, OPAIS records, Medicaid Exclusion File designations, and controls designed to prevent diversion and duplicate discounts.

Regular validation gives compliance teams a clearer picture of their data before an audit begins.

Instead of discovering a data problem when an auditor asks about it, the organization has a chance to identify and investigate the issue internally.

What Data Should Covered Entities Validate?

The exact review will depend on the organization’s structure and 340B model. However, several areas deserve regular attention.

OPAIS Information

Check whether registered sites, contract pharmacies, contact information, and other applicable details reflect current operations.

Medicaid Information

Review Medicaid billing arrangements and make sure information in the Medicaid Exclusion File matches actual practices. HRSA explains that covered entities must report how they handle Medicaid fee-for-service drugs through the applicable carve-in or carve-out process.

Patient and Prescription Data

Review relevant records to identify transactions that may not meet established eligibility rules or that require additional investigation.

Purchasing and Dispensing Data

Comparing purchasing records with dispensing and other transaction data can help identify unusual patterns, missing information, or mismatches.

Contract Pharmacy Data

Contract pharmacies add another layer of data that needs oversight. Organizations should review contract pharmacy activity and maintain appropriate controls.

How Should a 340B Data Validation Process Work?

A useful validation process does not need to be complicated. It should be consistent and connected to the organization’s actual compliance risks.

A basic process can look like this:

1. Collect the relevant data

Bring together information from the systems involved in the 340B workflow.

2. Check for inconsistencies

Look for missing records, duplicate entries, mismatched identifiers, outdated information, and unusual transactions.

3. Compare against trusted sources

Use appropriate source records and current program information to determine whether the data is accurate.

4. Investigate exceptions

Not every data mismatch represents a compliance violation. Each exception should be reviewed by the appropriate team.

5. Correct confirmed issues

If an error is confirmed, correct the underlying data and document what was changed.

6. Look for the root cause

If the same problem keeps appearing, determine why. The issue may come from a system configuration, manual process, staff training gap, or communication problem.

7. Keep evidence of the review

Document the validation process, findings, corrections, and follow-up actions.

What Are the Common Challenges With 340B Data Validation?

One of the biggest challenges is that 340B information often comes from multiple systems.

A healthcare organization may have separate systems for EHR data, pharmacy dispensing, purchasing, claims, billing, and contract pharmacy activity. These systems may use different formats or identifiers.

Another challenge is timing. A record can be correct when it is created but becomes outdated after a location, pharmacy relationship, billing process, or organizational structure changes.

For this reason, data validation should be an ongoing process rather than a one-time cleanup.

How Can Organizations Make Validation More Effective?

The first step is to focus on the areas that create the greatest compliance risk.

Organizations should:

• Define who owns each data source
• Establish clear validation rules
• Review high-risk transactions regularly
• Keep registration information current
• Document exceptions and corrections
• Train staff on the importance of accurate data
• Use automation where it makes sense
• Review recurring issues for root causes

A structured review of hospital eligibility information can also help teams understand whether their records are complete and consistent. For additional guidance on handling these types of requests, see this resource on 340B Program information requests and hospital eligibility.

Can Data Validation Replace a 340B Compliance Audit?

No. Data validation is a compliance control, not a replacement for a full audit.

Validation focuses on checking information and identifying potential problems. An audit is a broader review of compliance with applicable 340B requirements and internal controls.

The two processes work well together. Regular validation can give an organization better information to use during internal reviews and help identify areas that deserve a deeper audit.

Key Takeaways

340B data validation can reduce compliance risk by helping covered entities identify inaccurate, incomplete, or inconsistent information before it leads to a larger problem.

The most important areas to review include:

• OPAIS registration information
• Medicaid billing and exclusion data
• Patient and prescription records
• Purchasing and dispensing data
• Contract pharmacy activity
• Internal compliance records

Good data does not guarantee 340B compliance. But reliable data gives compliance teams a stronger foundation for making decisions, monitoring controls, investigating exceptions, and preparing for audits.

For covered entities, the goal should be more than correcting data when an issue appears. A regular validation process can help make data accuracy part of everyday 340B program compliance.